Acurx Pharmaceuticals Inc (ACXP)

Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Operating Expenses	14.40% 4.3779	5.1146	3.115	3.4452	2.903
Income/Loss From Continuing Operations Before Tax	14.40% -4.3779	-5.1146	-3.115	-3.4452	-2.903
Income/Loss From Continuing Operations After Tax	14.40% -4.3779	-5.1146	-3.115	-3.4452	-2.903
Net Income/Loss	14.40% -4.3779	-5.1146	-3.115	-3.4452	-2.903
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,872% 15.47	0.3896	13.01	12.19	11.64
Diluted Average Shares	3,872% 15.47	0.3896	13.01	12.19	11.64
Basic Earnings Per Share	26.32% -0.28	-0.38	-0.24	-0.28	-0.25
Diluted Earnings Per Share	26.32% -0.28	-0.38	-0.24	-0.28	-0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-